Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its ...

We recently published a list of 10 Stocks Skyrocketing Today. In this article, we are going to take a look at where Viking ...

Viking Therapeutics inks broad manufacturing pact with CordenPharma to support commercialization of VK2735: San Diego Wednesday, March 12, 2025, 17:00 Hrs [IST] Viking Therapeutic ...

This long-term agreement will help support the commercialization of VK2735.

Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...

Viking Therapeutics is partnering with Germany's CordenPharma to produce 1 billion GLP-1 pills a year and 100 million shots. Roche is meanwhile tying up with Denmark's Zealand Pharma to invent a ...

After Viking Therapeutics (VKTX) announced a multi-year manufacturing agreement with CordenPharma to support the commercialization of VK2735, ...